Inhibition of simian virus 40 replication by kanamycin derivative.
D000952:Antigens, Polyomavirus Transforming; D000957:Antigens, Viral, Tumor / Q000096:biosynthesis; D000998:Antiviral Agents / Q000494:pharmacology*; D004261:DNA Replication / Q000187:drug effects; D007612:Kanamycin / Q000031:analogs & derivatives* / Q000494:pharmacology; D009856:Oncogene Proteins, Viral / Q000096:biosynthesis; D013539:Simian virus 40 / Q000187:drug effects*; D014158:Transcription, Genetic / Q000187:drug effects; D014779:Virus Replication / Q000187:drug effects*
D000952:Antigens, Polyomavirus Transforming; D000957:Antigens, Viral, Tumor; D000998:Antiviral Agents; D009856:Oncogene Proteins, Viral; D007612:Kanamycin; C048726:1-eicosanoyl-3''-N-(trifluoroacetyl)kanamycin